We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
9
3 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1988
Active, not recruiting
3
33.3%
Completed
1
11.1%
Recruiting
2
22.2%
Terminated
Withdrawn
No approval data available
- The U.S. Department of Defense awarded $962,977 to Steadman Philippon Research Institute for a year-long clinical study exploring enhanced extracellular vesicles as osteoarthritis therapy. - Researchers will modify autologous extracellular vesicles using senolytic and anti-fibrotic drugs to reduce inflammation and promote joint regeneration in patients. - The study will test whether oral administration of dietary supplements or FDA-approved drugs can safely alter circulating extracellular vesicle composition to improve pain relief and slow disease progression.
